FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1538962425> ?p ?o ?g. }

• W1538962425 endingPage "55" @default.
• W1538962425 startingPage "46" @default.
• W1538962425 abstract "We aimed to explore the effects of (90)Y-DOTATOC and (90)Y-DOTATOC plus (177)Lu-DOTATOC on survival of patients with metastasized gastrinoma. Patients with progressive metastasized gastrinoma were treated with repeated cycles of (90)Y-DOTATOC or with cycles alternating between (90)Y-DOTATOC and (177)Lu-DOTATOC until tumor progression or permanent toxicity. Multivariable Cox regression analyses were used to study predictors of survival. A total of 36 patients were enrolled; 30 patients received (90)Y-DOTATOC (median activity per patient 11.8GBq; range: 6.1-62.2GBq) and 6 patients received (90)Y-DOTATOC plus (177)Lu-DOTATOC (median activity per patient: 14.8GBq; range: 7.4-14.8GBq). Response was found in 26 patients (72.2%), including morphological (n=12, 33.3%), biochemical (n=14, 38.9%) and/or clinical response (n=6, 16.2%). A total of 21 patients (58.3%) experienced hematotoxicity grade 1/2, while 1 patient (2.8%) experienced hematotoxicity grade 3; no grade 4 hematotoxicity occurred. Furthermore, 2 patients (5.6%) developed grade 4 renal toxicity; no grade 5 renal toxicity occurred. Responders had a significantly longer median survival from time of enrollment than non-responders (45.1 months, range: 37.1-53.1 months vs. 12.6 months, range: 11.0-14.2, hazard ratio: 0.12 (0.027-0.52), p=0.005). Additionally, there was a trend towards longer median survival with (90)Y-DOTATOC plus (177)Lu-DOTATOC as compared to (90)Y-DOTATOC alone (60.2 months, range: 19.8-100.6 months vs. 27.0 months, range: 4.0-50.0, hazard ratio: 0.21 (0.01-3.98), p=0.16). Response to (90)Y-DOTATOC and (90)Y-DOTATOC plus (177)Lu-DOTATOC therapy is associated with a longer survival in patients with metastasized gastrinoma. Both treatment regimens are promising tools for management of progressive gastrinoma." @default.
• W1538962425 created "2016-06-24" @default.
• W1538962425 creator A5007412548 @default.
• W1538962425 creator A5008765979 @default.
• W1538962425 creator A5012926096 @default.
• W1538962425 creator A5013094846 @default.
• W1538962425 creator A5029698599 @default.
• W1538962425 creator A5040850107 @default.
• W1538962425 creator A5054164361 @default.
• W1538962425 creator A5054179980 @default.
• W1538962425 creator A5067045410 @default.
• W1538962425 creator A5078822505 @default.
• W1538962425 date "2015-01-01" @default.
• W1538962425 modified "2023-10-17" @default.
• W1538962425 title "Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinoma." @default.
• W1538962425 cites W1695950268 @default.
• W1538962425 cites W1829445575 @default.
• W1538962425 cites W1917620582 @default.
• W1538962425 cites W1935825021 @default.
• W1538962425 cites W1966024289 @default.
• W1538962425 cites W1993899353 @default.
• W1538962425 cites W1996375200 @default.
• W1538962425 cites W1999715445 @default.
• W1538962425 cites W2009629472 @default.
• W1538962425 cites W2011187030 @default.
• W1538962425 cites W2012694635 @default.
• W1538962425 cites W2024035978 @default.
• W1538962425 cites W2036212440 @default.
• W1538962425 cites W2050316046 @default.
• W1538962425 cites W2092047830 @default.
• W1538962425 cites W2105649247 @default.
• W1538962425 cites W2113654090 @default.
• W1538962425 cites W2114802801 @default.
• W1538962425 cites W2115686439 @default.
• W1538962425 cites W2125859598 @default.
• W1538962425 cites W2137385634 @default.
• W1538962425 cites W2148881212 @default.
• W1538962425 cites W2156961571 @default.
• W1538962425 cites W2158474413 @default.
• W1538962425 cites W2321986725 @default.
• W1538962425 cites W2339290868 @default.
• W1538962425 cites W2398358039 @default.
• W1538962425 cites W2416345105 @default.
• W1538962425 cites W2494501693 @default.
• W1538962425 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4299770" @default.
• W1538962425 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25625026" @default.
• W1538962425 hasPublicationYear "2015" @default.
• W1538962425 type Work @default.
• W1538962425 sameAs 1538962425 @default.
• W1538962425 citedByCount "9" @default.
• W1538962425 countsByYear W15389624252016 @default.
• W1538962425 countsByYear W15389624252019 @default.
• W1538962425 countsByYear W15389624252020 @default.
• W1538962425 countsByYear W15389624252021 @default.
• W1538962425 countsByYear W15389624252023 @default.
• W1538962425 crossrefType "journal-article" @default.
• W1538962425 hasAuthorship W1538962425A5007412548 @default.
• W1538962425 hasAuthorship W1538962425A5008765979 @default.
• W1538962425 hasAuthorship W1538962425A5012926096 @default.
• W1538962425 hasAuthorship W1538962425A5013094846 @default.
• W1538962425 hasAuthorship W1538962425A5029698599 @default.
• W1538962425 hasAuthorship W1538962425A5040850107 @default.
• W1538962425 hasAuthorship W1538962425A5054164361 @default.
• W1538962425 hasAuthorship W1538962425A5054179980 @default.
• W1538962425 hasAuthorship W1538962425A5067045410 @default.
• W1538962425 hasAuthorship W1538962425A5078822505 @default.
• W1538962425 hasConcept C126322002 @default.
• W1538962425 hasConcept C207103383 @default.
• W1538962425 hasConcept C2776297358 @default.
• W1538962425 hasConcept C2776986829 @default.
• W1538962425 hasConcept C2781025020 @default.
• W1538962425 hasConcept C2781283050 @default.
• W1538962425 hasConcept C29730261 @default.
• W1538962425 hasConcept C2989005 @default.
• W1538962425 hasConcept C44249647 @default.
• W1538962425 hasConcept C49039625 @default.
• W1538962425 hasConcept C71924100 @default.
• W1538962425 hasConcept C90924648 @default.
• W1538962425 hasConceptScore W1538962425C126322002 @default.
• W1538962425 hasConceptScore W1538962425C207103383 @default.
• W1538962425 hasConceptScore W1538962425C2776297358 @default.
• W1538962425 hasConceptScore W1538962425C2776986829 @default.
• W1538962425 hasConceptScore W1538962425C2781025020 @default.
• W1538962425 hasConceptScore W1538962425C2781283050 @default.
• W1538962425 hasConceptScore W1538962425C29730261 @default.
• W1538962425 hasConceptScore W1538962425C2989005 @default.
• W1538962425 hasConceptScore W1538962425C44249647 @default.
• W1538962425 hasConceptScore W1538962425C49039625 @default.
• W1538962425 hasConceptScore W1538962425C71924100 @default.
• W1538962425 hasConceptScore W1538962425C90924648 @default.
• W1538962425 hasIssue "1" @default.
• W1538962425 hasLocation W15389624251 @default.
• W1538962425 hasOpenAccess W1538962425 @default.
• W1538962425 hasPrimaryLocation W15389624251 @default.
• W1538962425 hasRelatedWork W105130885 @default.
• W1538962425 hasRelatedWork W1996375200 @default.
• W1538962425 hasRelatedWork W2001238678 @default.
• W1538962425 hasRelatedWork W2043078679 @default.

• next